Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro J Marcos

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Archivos De Bronconeumologia|May 3, 2017
Treatment With Systemic Steroids in Severe Chronic Obstructive Pulmonary Disease Exacerbations: Use of Short Regimens in Routine Clinical Practice and Their Impact on Hospital StayPedro J Marcos, Irene Nieto-Codesido, Santiago de Jorge Dominguez-Pazos, et al.
Chest|June 9, 2012
Hypocapnia and hypercapnia are predictors for ICU admission and mortality in hospitalized patients with community-acquired pneumoniaElena Laserna, Oriol Sibila, Patrick R Aguilar, et al.
Respiration; International Review of Thoracic Diseases|July 25, 2018
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre StudyAna Rodrigo-Troyano, Valentina Melo, Pedro J Marcos, et al.
Canadian Respiratory Journal|April 23, 2019
Influenza A H1N1 Community-Acquired Pneumonia: Characteristics and Risk Factors-A Case-Control StudyRomina Abelleira, Alberto Ruano-Ravina, Adriana Lama, et al.
Medicina Clinica (English Ed.)|December 12, 2022
Survival impact of previous statin therapy in patients hospitalized with COVID-19Eduardo Barge-Caballero, Pedro J Marcos-Rodríguez, Nieves Domenech-García, et al.
Journal of Thoracic Disease|July 26, 2017
Discordance of physician clinical judgment <i>vs</i>. pneumonia severity index (PSI) score to admit patients with low risk community-acquired pneumonia: a prospective multicenter studyPedro J Marcos, Marcos I Restrepo, Francisco J González-Barcala, et al.
Medicina Clinica|May 26, 2022
[Survival impact of previous statin therapy in patients hospitalized with COVID-19]Eduardo Barge-Caballero, Pedro J Marcos-Rodríguez, Nieves Domenech-García, et al.
Archivos De Bronconeumologia|June 1, 2015
Validation of the Spanish Version of the COPD-Q Questionnaire on COPD KnowledgeLuis Puente-Maestu, Jorge Chancafe-Morgan, Myriam Calle, et al.
Respirology (Carlton, Vic.)|August 7, 2019
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumoniaDavid Villafuerte, Stefano Aliberti, Nilam J Soni, et al.
Archivos De Bronconeumologia|November 14, 2022
Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired PneumoniaSergi Pascual-Guardia, Francesco Amati, Judith Marin-Corral, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Archivos De Bronconeumologia|May 3, 2017
Treatment With Systemic Steroids in Severe Chronic Obstructive Pulmonary Disease Exacerbations: Use of Short Regimens in Routine Clinical Practice and Their Impact on Hospital StayPedro J Marcos, Irene Nieto-Codesido, Santiago de Jorge Dominguez-Pazos, et al.
Chest|June 9, 2012
Hypocapnia and hypercapnia are predictors for ICU admission and mortality in hospitalized patients with community-acquired pneumoniaElena Laserna, Oriol Sibila, Patrick R Aguilar, et al.
Respiration; International Review of Thoracic Diseases|July 25, 2018
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre StudyAna Rodrigo-Troyano, Valentina Melo, Pedro J Marcos, et al.
Canadian Respiratory Journal|April 23, 2019
Influenza A H1N1 Community-Acquired Pneumonia: Characteristics and Risk Factors-A Case-Control StudyRomina Abelleira, Alberto Ruano-Ravina, Adriana Lama, et al.
Medicina Clinica (English Ed.)|December 12, 2022
Survival impact of previous statin therapy in patients hospitalized with COVID-19Eduardo Barge-Caballero, Pedro J Marcos-Rodríguez, Nieves Domenech-García, et al.
Journal of Thoracic Disease|July 26, 2017
Discordance of physician clinical judgment <i>vs</i>. pneumonia severity index (PSI) score to admit patients with low risk community-acquired pneumonia: a prospective multicenter studyPedro J Marcos, Marcos I Restrepo, Francisco J González-Barcala, et al.
Medicina Clinica|May 26, 2022
[Survival impact of previous statin therapy in patients hospitalized with COVID-19]Eduardo Barge-Caballero, Pedro J Marcos-Rodríguez, Nieves Domenech-García, et al.
Archivos De Bronconeumologia|June 1, 2015
Validation of the Spanish Version of the COPD-Q Questionnaire on COPD KnowledgeLuis Puente-Maestu, Jorge Chancafe-Morgan, Myriam Calle, et al.
Respirology (Carlton, Vic.)|August 7, 2019
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumoniaDavid Villafuerte, Stefano Aliberti, Nilam J Soni, et al.
Archivos De Bronconeumologia|November 14, 2022
Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired PneumoniaSergi Pascual-Guardia, Francesco Amati, Judith Marin-Corral, et al.
Pageof 6